Response to “Ipilimumab (Yervoy) and the TGN1412 catastrophe”

Title
Response to “Ipilimumab (Yervoy) and the TGN1412 catastrophe”
Authors
Keywords
-
Journal
IMMUNOBIOLOGY
Volume 217, Issue 6, Pages 590-592
Publisher
Elsevier BV
Online
2011-11-18
DOI
10.1016/j.imbio.2011.11.001

Ask authors/readers for more resources

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation